|
Name |
Destruxin A4
|
Molecular Formula | C30H49N5O7 | |
IUPAC Name* |
(3R,19S)-13,16-di(butan-2-yl)-10,11,14-trimethyl-3-prop-2-enyl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
|
|
SMILES |
CCC(C)C1C(=O)N(C(C(=O)N(C(C(=O)NCCC(=O)O[C@@H](C(=O)N2CCC[C@H]2C(=O)N1)CC=C)C)C)C(C)CC)C
|
|
InChI |
InChI=1S/C30H49N5O7/c1-9-13-22-28(39)35-17-12-14-21(35)27(38)32-24(18(4)10-2)29(40)34(8)25(19(5)11-3)30(41)33(7)20(6)26(37)31-16-15-23(36)42-22/h9,18-22,24-25H,1,10-17H2,2-8H3,(H,31,37)(H,32,38)/t18?,19?,20?,21-,22+,24?,25?/m0/s1
|
|
InChIKey |
HLRYHDDTULAZQQ-LSGBTAIHSA-N
|
|
Synonyms |
Destruxin A4
|
|
CAS | NA | |
PubChem CID | 139585083 | |
ChEMBL ID | CHEMBL2372204 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 591.7 | ALogp: | 2.6 |
HBD: | 2 | HBA: | 7 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 145.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 42 | QED Weighted: | 0.353 |
Caco-2 Permeability: | -5.175 | MDCK Permeability: | 0.00000948 |
Pgp-inhibitor: | 0.988 | Pgp-substrate: | 0.614 |
Human Intestinal Absorption (HIA): | 0.912 | 20% Bioavailability (F20%): | 0.053 |
30% Bioavailability (F30%): | 0.886 |
Blood-Brain-Barrier Penetration (BBB): | 0.247 | Plasma Protein Binding (PPB): | 64.86% |
Volume Distribution (VD): | 0.408 | Fu: | 35.95% |
CYP1A2-inhibitor: | 0.001 | CYP1A2-substrate: | 0.071 |
CYP2C19-inhibitor: | 0.045 | CYP2C19-substrate: | 0.648 |
CYP2C9-inhibitor: | 0.039 | CYP2C9-substrate: | 0.116 |
CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.116 |
CYP3A4-inhibitor: | 0.893 | CYP3A4-substrate: | 0.763 |
Clearance (CL): | 4.882 | Half-life (T1/2): | 0.852 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.641 |
Drug-inuced Liver Injury (DILI): | 0.506 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.729 | Maximum Recommended Daily Dose: | 0.423 |
Skin Sensitization: | 0.045 | Carcinogencity: | 0.004 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.014 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003706 | 0.714 | D05AFC | 0.253 | ||||
ENC003271 | 0.614 | D08FJL | 0.251 | ||||
ENC003692 | 0.429 | D0L7LC | 0.250 | ||||
ENC002484 | 0.422 | D0E2OU | 0.248 | ||||
ENC002483 | 0.399 | D0P8IV | 0.244 | ||||
ENC005563 | 0.392 | D02IQY | 0.242 | ||||
ENC004972 | 0.354 | D0L9HX | 0.237 | ||||
ENC005975 | 0.354 | D0D8XY | 0.237 | ||||
ENC003559 | 0.343 | D02SBQ | 0.236 | ||||
ENC002857 | 0.341 | D06YFA | 0.235 |